(Q38701265)

5 September 2017

How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach (English)

1 reference

small intestinal bacterial overgrowth

5 September 2017

0 references

2

Mark Pimentel

1 reference

5 September 2017

Ali Rezaie

1

1 reference

PubMed ID

26780631

5 September 2017

Satish S Rao

series ordinal

3

1 reference

5 September 2017

1 January 2016

1 reference

Current gastroenterology reports

5 September 2017

1 reference

5 September 2017

18

1 reference

5 September 2017

2

1 reference

5 September 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1007/s11894-015-0482-9

5 September 2017

0 references

cites work

Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Risk factors for small bowel bacterial overgrowth and diagnostic yield of duodenal aspirates in children with intestinal failure: a retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Small intestinal bacterial overgrowth syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Irritable bowel syndrome and small intestinal bacterial overgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Abnormal intestinal motor patterns explain enteric colonization with gram-negative bacilli in late radiation enteropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Small intestinal bacterial overgrowth in gastroparesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Brain-gut-microbiota axis in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Small intestinal bacterial overgrowth in patients with chronic pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Review article: small intestinal bacterial overgrowth--prevalence, clinical features, current and developing diagnostic tests, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

A systematic review of diagnostic tests for small intestinal bacterial overgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Use and abuse of hydrogen breath tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Methane on breath testing is associated with constipation: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

The degree of breath methane production in IBS correlates with the severity of constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Rifaximin therapy for patients with irritable bowel syndrome without constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Antibiotic treatment of constipation-predominant irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Methanogens, methane and gastrointestinal motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

A 14-day elemental diet is highly effective in normalizing the lactulose breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Small intestinal bacterial overgrowth recurrence after antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

The interdigestive myo-electric complex of the stomach and small bowel of dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

The migrating motor complex: control mechanisms and its role in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Lactose intolerance and the role of the lactose breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Visceroptosis of the bowel in the hypermobility type of Ehlers-Danlos syndrome: presentation of a rare manifestation and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Probiotics for antibiotic-associated diarrhea: PLACIDE swings the pendulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0482-9

Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole

21 January 2018

1 reference

12 December 2020

Volume, composition, and source of intestinal gas.

1 reference

12 December 2020

Diets that differ in their FODMAP content alter the colonic luminal microenvironment

1 reference

12 December 2020

Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath tests

1 reference

12 December 2020

Intestinal methane production in obese individuals is associated with a higher body mass index

1 reference

12 December 2020

A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test

1 reference

12 December 2020

Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension

1 reference

12 December 2020

Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth.

1 reference

12 December 2020

Studies in metabolic nutrition employing chemically defined diets. II. Effects on gut microflora populations.

1 reference

12 December 2020

The treatment of small intestinal bacterial overgrowth with enteric-coated peppermint oil: a case report

1 reference

12 December 2020

New and Emerging Treatment Options for Irritable Bowel Syndrome

1 reference

12 December 2020

Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

All the commercially available adhesion barriers have the same effect on adhesion prophylaxis?; A comparison of barrier agents using a newly developed, severe intra-abdominal adhesion model

1 reference

12 December 2020

Short- and long-term effects of a lactose-restricted diet and probiotics in children with chronic abdominal pain: a retrospective study

1 reference

12 December 2020

10.1007/S11894-015-0482-9

Identifiers

DOI

1 reference

PubMed ID

26780631

Dimensions Publication ID

5 September 2017

0 references

1 reference

PubMed ID

26780631